Shiro Ueno - Concepedia

Author

Shiro Ueno

University of Miyazaki

Also Known As

Shiro UENO, Shiro Ueno

Publications

163

Citations

H-Index

Concepts

All Affiliations

University of Miyazaki Nagasaki University

About

Shiro Ueno is an author at University of Miyazaki specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	80
2	Immunology	3	3	61
3	Allergy	2	2	45
4	Pathology	1	1	16
5	Pharmacology	1	1	19

Shiro Ueno

Publications

130

Citations

H-Index

Page 1

	Year	Citations
Leukocytapheresis (LCAP) decreases the level of platelet-derived microparticles (MPs) and increases the level of granulocytes-derived MPs: a possible connection with the effect of LCAP on rheumatoid arthritis Kunihiko Umekita, Toshihiko Hidaka, Shiro Ueno, Modern Rheumatology Granulocytes-derived MpsImmunologyInflammationRheumatoid DisorderHematology	2009	27
Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4 Daiki Ogawara, Minoru Fukuda, Shiro Ueno, Supportive Care in Cancer Therapeutic Drug MonitoringHyperthermiaMedicinePharmacologyPosttreatment Days 3	2015	19
Treatment With Anti–Tumor Necrosis Factor Biologic Agents in Human T Lymphotropic Virus Type I–Positive Patients With Rheumatoid Arthritis Kunihiko Umekita, Toshihiko Hidaka, Shunichi Miyauchi, Arthritis Care & Research	2013	18
Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series Kunihiko Umekita, Kazumi Umeki, Shunichi Miyauchi, Modern Rheumatology	2013	18
Leukocytapheresis (LCAP) decreases the level of platelet-derived microparticles (MPs) and increases the level of granulocytes-derived MPs: a possible connection with the effect of LCAP on rheumatoid arthritis Kunihiko Umekita, Toshihiko Hidaka, Shiro Ueno, Modern Rheumatology InflammationRheumatologyPlatelet-derived MicroparticlesGranulocytes-derived MpsThrombopoiesis	2009	18
Proviral loads of human T‐lymphotropic virus Type 1 in asymptomatic carriers with different infection routes Shiro Ueno, Kazumi Umeki, Ichiro Takajo, International Journal of Cancer ImmunodeficienciesImmunologyPathologyImmunotherapyCancer-associated Virus	2011	16
Defective human T‐lymphotropic virus type 1 provirus in asymptomatic carriers Hiroyuki Takenouchi, Kazumi Umeki, Daisuke Sasaki, International Journal of Cancer	2010	14

Page 1